Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients

Kanbay, Mehmet; Afsar, Barış; Siriopol, Dimitrie; Unal, Hilmi; Karaman, Murat; Saglam, Mutlu; Eyileten, Tayfun; Gezer, Mustafa; Verim, Samet; Oguz, Yusuf; Vural, Abdulgaffar; Ortiz, Alberto; Johnson, Richard; Covic, Adrian; Yilmaz, Mahmut

doi:10.1007/s11255-016-1271-6

Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients

Kanbay M., Afsar B., Siriopol D., Unal H. U., Karaman M., Saglam M., ...Daha Fazla

INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.48, sa.7, ss.1129-1136, 2016 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 48 Sayı: 7
Basım Tarihi: 2016
Doi Numarası: 10.1007/s11255-016-1271-6
Dergi Adı: INTERNATIONAL UROLOGY AND NEPHROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1129-1136
Süleyman Demirel Üniversitesi Adresli: Evet

Özet

Both elevated serum uric acid and serum asymmetric dimethylarginine (ADMA) are risk factors for cardiovascular disease. We hypothesized that combined elevation of uric acid and ADMA amplifies the risk of all-cause mortality and/or cardiovascular events (CVE) in patients with chronic kidney disease (CKD).